Ras (p21ras) interacts directly with the catalytic subunit of phosphatidylinositol-3-OH kinase in a GTP-dependent manner through the Ras effector site. In vivo, dominant negative Ras mutant N17 inhibits growth factor induced production of 3′ hosphorylated phosphoinositides in PC12 cells, and transfection of Ras, but not Raf, into COS cells results in a large elevation in the level of these lipids. Therefore Ras can probably regulate phosphatidylinositol-3-OH kinase, providing a point of divergence in signalling pathways downstream of Ras.
The VPS 34 gene product (Vps34p) is required for protein sorting to the lysosome-like vacuole of the yeast Saccharomyces cerevisiae . Vps34p shares significant sequence similarity with the catalytic subunit of bovine phosphatidylinositol (PI) 3-kinase [the 110-kilodalton (p110) subunit of PI 3-kinase], which is known to interact with activated cell surface receptor tyrosine kinases. Yeast strains deleted for the VPS 34 gene or carrying vps 34 point mutations lacked detectable PI 3-kinase activity and exhibited severe defects in vacuolar protein sorting. Overexpression of Vps34p resulted in an increase in PI 3-kinase activity, and this activity was specifically precipitated with antisera to Vps34p. VPS 34 encodes a yeast PI 3-kinase, and this enzyme appears to regulate intracellular protein trafficking decisions.
Phosphoinositide (PI) 3-kinase was first observed in 1984 as a minor inositol lipid kinase activity associated with immunoprecipitated oncogene products (e.g. Src, Abl and polyoma mT antigen) and present in activated growth factor receptor complexes (e.g. PDGF receptor). In 1988, the enzyme associated with this activity was found to have the novel ability to phosphorylate the 3 position hydroxyl group of the inositol ring (see poster) of phosphatidylinositol (PtdIns). PI 3-kinase activities have been subsequently found in all eukaryotic cell types examined (Fry, 1994; Katso et al., 2001) and are linked to an incredibly diverse set of key cellular functions, including cell growth, proliferation, motility, differentiation, survival and intracellular trafficking (Fry, 1994; Rameh and Cantley, 1999; Fry, 2001; Katso et al., 2001). The emerging links between PI 3-kinase activity and many human maladies, including allergy, inflammation, heart disease and cancer, has made them the focus of intense study, and inhibitors of these enzymes are considered potential therapeutic agents (Stein and Waterfield, 2000).
Axin promotes the phosphorylation of β‐catenin by GSK‐3β, leading to β‐catenin degradation. Wnt signals interfere with β‐catenin turnover, resulting in enhanced transcription of target genes through the increased formation of β‐catenin complexes containing TCF transcription factors. Little is known about how GSK‐3β‐mediated β‐catenin turnover is regulated in response to Wnt signals. We have explored the relationship between Axin and Dvl‐2, a member of the Dishevelled family of proteins that function upstream of GSK‐3β. Expression of Dvl‐2 activated TCF‐dependent transcription. This was blocked by co‐expression of GSK‐3β or Axin. Expression of a 59 amino acid GSK‐3β‐binding region from Axin strongly activated transcription in the absence of an upstream signal. Introduction of a point mutation into full‐length Axin that prevented GSK‐3β binding also generated a transcriptional activator. When co‐expressed, Axin and Dvl‐2 co‐localized within expressing cells. When Dvl‐2 localization was altered using a C‐terminal CAAX motif, Axin was also redistributed, suggesting a close association between the two proteins, a conclusion supported by co‐immunoprecipitation data. Deletion analysis suggested that Dvl‐association determinants within Axin were contained between residues 603 and 810. The association of Axin with Dvl‐2 may be important in the transmission of Wnt signals from Dvl‐2 to GSK‐3β.